Printer Friendly

Medimmune Deals Briefing Provides a Comprehensive Summary of the Deals and Alliances Announced by the Company between 2001 and 2006.

DUBLIN, Ireland -- Research and Markets ( has announced the addition of MedImmune Deals Briefing to their offering

MedImmune Deals Briefing provides an in-depth view of the 29 deals made by MedImmune and its subsidiaries with 30 partnering companies between 2001 and 2006, in a clear and accessible PDF format.

Chapter 1: Company profile

An overview of the company, including contact details, and expertise in terms of industry sector, therapy focus and management.

Chapter 2: Financial data and deals overview

A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3: Summary of deals

A comprehensive overview listing deals by partner company, subsidiary, therapy focus, development stage, deal type and industry sector with a full index of all the deals announced.

Chapter 4: List of deals

A detailed listing of all the company's deals and alliances announced between January 2001 and March 2006.

Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront and milestone payments, where disclosed.

Reasons to Purchase

MedImmune Deals Briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2001 and March 2006. This report helps in:

- identifying active partners

- tracking competitor activity

- benchmarking deals

- comparing the finances of different deal types.

MedImmune Deals Briefing brings all relevant partnering deals into one place, providing a reference to deal making by MedImmune.

Scope of This Report

The report contains:

- a brief company profile including subsidiary names

- financial information where disclosed

- a deals overview

- specialized indexes including deals by partner company, subsidiary company, therapy focus, development stage, deal type and industry sector.

- a detailed listing of the company's deals and alliances.

Forecasts, Projections, Market Estimates

This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.

Who Should Buy the Report

This report is essential reading for board and executive management, and individuals in:

- business development

- licensing/partnering

- deal making

- business strategy

- marketing and promotion

- distribution and manufacturing (including contract services).


This report is derived from data obtained from Pharmalicensing's Partneringdesk deals and alliances database. The database is updated daily using industry sources.

Chapters are as follows:-


About Partneringdesk Deals Briefings

Chapter 1: Company profile

Chapter 2: Financial data and deals overview

Chapter 3: Summary of deals

Chapter 4: List of deals


List of Tables

- Aviron

- Cellective Therapeutics Inc

For more information visit
COPYRIGHT 2006 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 26, 2006
Previous Article:In 2005, the Plus-Size Segment Was Valued at Roughly $32 Billion, Accounting for over 75% of the Total Plus-Size, Petite and Maternity Wear Market.
Next Article:Otc Cough and Throat Remedy Industry Tied Largely to the Cold and Flu Period of the Year - Cough and Throat Products in the United States.

Related Articles
Astrazeneca Deals Briefing Covered 106 Deals Made between 2000 and 2005.
An in-Dept View Of Solvay SA Covering Its 52 Partnering Companies and 46 Deals Made by the Company from 2000 - 2005.
A Company Review of Teva Pharmaceutical Industries Ltd Including Information on 75 Deals Made and 76 Partnering Companies from 2000 - 2005.
A Review of UCB Pharma Including Their 14 Deals Made, 19 Partnering Companies, and Financial Information.
A Company Analysis of Yamanouchi Pharmaceutical Co Ltd Offering Information about Their Deals Made, Partnering Companies, and Financial Information.
A Five Year Analysis of Takeda Pharmaceutical Co Ltd Including Information about Their 48 Deals Made and 54 Partnering Companies.
Research and Markets: View a Detailed Listing of All Ranbaxy Laboratories Deals and Alliances Announced between January 2001 and March 2006.
Research and Markets: Get an in-Depth View of over 49 Deals Made by Biogen Idec.
Research and Markets: Analysis of the Deals Made by Dainippon Sumitomo Pharma Co Ltd over a Five Year Period.
Research and Markets: Partneringdesk Astellas Pharma Inc Deals Briefing Provides a Comprehensive Summary of the Deals and Alliances During January...

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters